Editors

Jason Yuan // Editor-in-Chief

Jason Yuan.png

Jason Yuan is Professor of Medicine at the University of San Diego and Associate Director of Research Training (Basic Science). His research interests include pulmonary vascular pathophysiology and pathogenic mechanisms of pulmonary vascular disease. He received his medical school training at Suzhou Medical College (China), his PhD at Peking Union Medical College (China), and his postdoctoral training in the University of Maryland School of Medicine. He is a Fellow of the American Heart Association, the American Association for the Advancement of Science, and the American Physiological Society. He is also a Guggenheim Fellow, and an elected Member of the American Society for Clinical Investigation and the Association of American Physicians. He has served on many advisory committees and editorial boards, including Chair of the Respiratory Integrative Biology and Translational Research study section of the National Institutes of Health (NIH), and Chair of the Pulmonary Circulation Assembly of the American Thoracic Society. He is currently a regular member of the Vascular Cell and Molecular Biology study section and Deputy Editor of the American Journal of Physiology Cell Physiology. His pulmonary vascular disease research propels the field on pathogenic roles of membrane receptors and ion channels and provides a new research direction for developing therapeutic approaches for the disease.

Nick Morrell // Editor-in-Chief

Nick Morrell

Nick Morrell MD ScD FRCP FMedSci qualified in Medicine (MB BS) from Charing Cross and Westminster Medical School (now Imperial College, London) in 1987. He undertook his research MD at Charing Cross Hospital and then spent two years in Denver, Colorado, as a British Heart Foundation fellow before returning as a Lecturer to complete training in General and Respiratory Medicine at the Royal Postgraduate Medical School, Hammersmith Hospital. He was appointed Senior Lecturer and Honorary Consultant at Hammersmith Hospital, Imperial College in 1998 and was awarded an MRC Clinician Scientist Fellowship. He moved to the University of Cambridge in 2000 as University Lecturer and Honorary Consultant at Addenbrooke’s and Papworth Hospitals, and was appointed Professor of Cardiopulmonary Medicine in 2007.

In 2009, he was awarded a British Heart Foundation Professorship and in 2011 elected to the fellowship of the Academy of Medical Sciences of the UK. He has chaired the programme committees for the British and American Thoracic Societies. He has served on the MRC Clinical Fellowships Committee, and was Director of the BHF Cambridge Centre for Cardiovascular Research Excellence (2014-2019) and leads the Cardiovascular and RespiratoryTheme of the NIHR Cambridge Biomedical Research Centre. He is Research Director of the National Pulmonary Vascular Diseases Unit at Papworth Hospital and a National Institute of Health Research Senior Investigator.

His research focuses on understanding genetic causes of pulmonary arterial hypertension, and developing new treatments based on this knowledge. He has published over 220 papers in this field. More recently he has been involved in exciting new genomics initiatives in the UK to apply whole genome sequencing to understanding the genetic basis of rare diseases, including pulmonary arterial hypertension, and to apply this technology to the direct care of patients.

Kurt Stenmark // Deputy Editor

Kurt Stenmark.png

Kurt Stenmark is Professor of Pediatrics, Head of the Division of Pediatric Critical Care Medicine and Director, Cardiovascular Pulmonary Research Laboratory at the University of Colorado Denver (UCD) and The Children’s Hospital Colorado in Aurora, Colorado. He joined the Pediatric faculty at UCD in 1984 as an Assistant Professor, was made Associate Professor with Tenure in 1989, and full Professor with Tenure in 1994. He has been the Division Head of Pediatric Critical Care Medicine since 1987.

Co-author of over 291 publications, Dr. Stenmark is currently Principal Investigator on a number of NIH grants (including a PPG, R01 Axis, and a T-32 Training Grant) in the areas of immature pulmonary circulation, hypoxic vascular modeling, and pediatric pulmonary disease. Additionally, he provides research support on a number of other NIH grants. Since 1984, the NIH has continuously funded him. He has received numerous international honors and awards, sits on several national and international committees as well as major grant review committees in his field (permanent member of RIBT and NHLBI). He currently serves as an Associate Editor for American Journal of Physiology, Lung, Cellular, and Molecular Physiology, Deputy Editor for Pulmonary Circulation, a journal of the PVRI, and is on the Editorial Board of other noted journals. He is an Affiliated Faculty for the Center for Global Health, at the University of Colorado School of Public Health. Dr. Stenmark has been a visiting professor or invited speaker throughout Europe and North America.

Dr. Stenmark has served in the capacity of both Chair of the Pulmonary Circulation Nominating Committee and Chair of the Pulmonary Circulation Section of the ATS. He has served on the planning committee for several international vascular biology meetings, for the ATS sponsored Grover Conference on the Pulmonary Circulation and on the Planning Committee for the International Meeting in the Pulmonary Circulation in Beijing, China. Most recently he was appointed to the Pulmonary Vascular Research Institute (PVRI) Steering and Scientific Committee as well as to the PVRI Liaison, Cardiopulmonary, Critical Care, Perioperative & Resuscitation (3CPR) Council. Dr. Stenmark is the honored recipient of the 2015 Robert F. Grover Prize from the American Thoracic Society.

Irene Lang // Deputy Editor

Irene Lang.png

Irene Lang is a senior staff member at the Department of Cardiology, and Deputy Chair of the Department, at the Medical University of Vienna, Vienna, Austria. She has been Professor of Vascular Biology at the Medical University of Vienna since 2004, where she leads a clinical and experimental group in vascular medicine focusing on pulmonary vascular biology and right ventricular function. Dr. Lang is an active interventional and structural cardiologist, recently very active as balloon pulmonary angioplasty interventionist, and an active researcher. She was nominated by the World Medical Association as a ‘Caring Physician of the World’ in 2006, ‘Teacher of the Year’ at MUV in 2013, and is past president of the Austrian Society of Cardiology.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg